Welcome, here are Medical News Todayâs headlines for June 20, 2020. |
|
Welcome to today's MNT newsletter, bringing you the most recent headlines and updated stories from our team of expert writers. Stay informed with the latest developments in the current COVID-19 pandemic and our dedicated COVID-19 daily newsletter. |
| Biology / Biochemistry |
| Duo of antiviral drugs strongly inhibits SARS-CoV-2 in the lab A combination of two antiviral drugs can strongly inhibit the new coronavirus in cell culture experiments, potentially paving the way for a treatment. |
| Diabetes |
| Soliqua 100/33 (insulin glargine/lixisenatide) Soliqua 100/33 (insulin glargine/lixisenatide) is a brand-name prescription medication that's used with diet and exercise to improve blood sugar levels in adults with type 2 diabetes. It comes as a pen that you use to inject the drug under your skin. Learn about dosage, side effects, warnings, and more. |
| Does acupuncture for diabetes work? Acupuncture has many uses, and some research has suggested that it may work for diabetes, although scientists have not explained how it might work. Find out about the types of acupuncture that might help, the risks, and some evidence of its benefits. Anyone considering acupuncture should first check with their doctor. |
| Men's Health |
| Do all men die equally? The most common cause of death in men is heart disease. When breaking down the data, this does not hold true for all males. We explore why. |
| You are receiving this newsletter because you subscribed on our web site, Medical News Today. To unsubscribe from these newsletters, please click here. Contact MNT | Privacy Policy © 2020 Healthline Media UK Limited, a Red Ventures company 660 3rd Street, San Francisco, CA 94107 |
